back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-06-05 10:26 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-141,011 vol |
0 | |
| Filed 2024-06-05 10:26 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-81,000 vol |
0 | |
| Filed 2023-06-14 17:39 Tx date 2023-06-14 |
$FUSN
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,000 vol |
81,000 | |
| Filed 2022-06-22 22:03 Tx date 2022-06-14 |
$FUSN
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,000 vol |
64,000 | |
| Filed 2021-06-07 16:50 Tx date 2021-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,000 vol |
47,000 | |
| Filed 2020-07-03 17:20 Tx date 2020-06-25 |
$
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
| Filed 2020-07-03 17:19 Tx date 2020-06-25 |
$
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
141,011 |